NO20042713L - Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus - Google Patents

Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus

Info

Publication number
NO20042713L
NO20042713L NO20042713A NO20042713A NO20042713L NO 20042713 L NO20042713 L NO 20042713L NO 20042713 A NO20042713 A NO 20042713A NO 20042713 A NO20042713 A NO 20042713A NO 20042713 L NO20042713 L NO 20042713L
Authority
NO
Norway
Prior art keywords
glibenclamide
metformin
treatment
type
diabetes mellitus
Prior art date
Application number
NO20042713A
Other languages
English (en)
Inventor
Alessandro Tosetti
Mauro Guiducci
Giovanni Viti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042713(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of NO20042713L publication Critical patent/NO20042713L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042713A 2001-11-29 2004-06-28 Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus NO20042713L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
PCT/EP2002/013497 WO2003045355A1 (en) 2001-11-29 2002-11-29 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus

Publications (1)

Publication Number Publication Date
NO20042713L true NO20042713L (no) 2004-07-16

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042713A NO20042713L (no) 2001-11-29 2004-06-28 Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus

Country Status (40)

Country Link
US (1) US20050053661A1 (no)
EP (1) EP1458364B1 (no)
JP (1) JP4474162B2 (no)
KR (1) KR20040079898A (no)
CN (1) CN1596103B (no)
AR (1) AR037407A1 (no)
AT (1) ATE387190T1 (no)
AU (1) AU2002358061B2 (no)
BR (1) BR0214403A (no)
CA (1) CA2466677A1 (no)
CO (1) CO5590906A2 (no)
CY (1) CY1107966T1 (no)
DE (1) DE60225331T2 (no)
DK (1) DK1458364T3 (no)
EA (1) EA006766B1 (no)
EG (1) EG24124A (no)
ES (1) ES2302862T3 (no)
HK (1) HK1069974A1 (no)
HN (1) HN2002000341A (no)
HR (1) HRP20040501A2 (no)
HU (1) HUP0402154A3 (no)
IL (1) IL162143A0 (no)
IT (1) ITFI20010230A1 (no)
MA (1) MA27087A1 (no)
MX (1) MXPA04004974A (no)
MY (1) MY141243A (no)
NO (1) NO20042713L (no)
NZ (1) NZ533779A (no)
PA (1) PA8559801A1 (no)
PE (1) PE20030580A1 (no)
PL (1) PL206016B1 (no)
PT (1) PT1458364E (no)
RS (1) RS50937B (no)
SI (1) SI1458364T1 (no)
SV (1) SV2004001415A (no)
TN (1) TNSN04095A1 (no)
UA (1) UA81615C2 (no)
UY (1) UY27549A1 (no)
WO (1) WO2003045355A1 (no)
ZA (1) ZA200404880B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349531A1 (en) * 2001-01-12 2003-10-08 Sun Pharmaceuticals Industries Ltd. Spaced drug delivery system
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
ES2760464T3 (es) 2003-04-29 2020-05-14 Nalpropion Pharmaceuticals Inc Composiciones para afectar a la pérdida de peso
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
US8088786B2 (en) * 2006-11-09 2012-01-03 Orexigen Therapeutics, Inc. Layered pharmaceutical formulations
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
WO2009158114A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
KR20120124423A (ko) 2010-01-11 2012-11-13 오렉시젠 세러퓨틱스 인크. 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
PT2661266T (pt) 2011-01-07 2020-11-30 Anji Pharma Us Llc Terapias com base em ligandos do recetor quimiossensorial
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
CN110693867A (zh) 2012-01-06 2020-01-17 埃尔舍利克斯治疗公司 用于治疗代谢性病症的组合物和方法
EA201491335A1 (ru) 2012-01-06 2015-04-30 Элселикс Терапьютикс, Инк. Бигуанидные композиции и способы лечения метаболических расстройств
PL2858640T3 (pl) 2012-06-06 2020-10-05 Nalpropion Pharmaceuticals Llc Kompozycja do zastosowania w sposobie leczenia nadwagi i otyłości u pacjentów z wysokim ryzykiem sercowo-naczyniowym
CN107072997A (zh) 2014-11-11 2017-08-18 盐野义制药株式会社 含有对光不稳定的药物的多层片剂
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
ID26082A (id) * 1998-03-19 2000-11-23 Briston Myers Squib Company Sistem pengiriman lepas terkendali dwifasa untuk zat-zat farmasi kelarutan tinggi dan metodenya
SI0974356T1 (en) * 1998-07-15 2003-12-31 Merck Sante Tablets comprising a combination of metformin and glibenclamide
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
EP1349531A1 (en) * 2001-01-12 2003-10-08 Sun Pharmaceuticals Industries Ltd. Spaced drug delivery system

Also Published As

Publication number Publication date
US20050053661A1 (en) 2005-03-10
ITFI20010230A1 (it) 2003-05-29
MY141243A (en) 2010-03-31
HRP20040501A2 (en) 2004-12-31
PT1458364E (pt) 2008-05-26
DK1458364T3 (da) 2008-06-23
DE60225331D1 (de) 2008-04-10
AU2002358061B2 (en) 2007-01-11
CN1596103A (zh) 2005-03-16
HN2002000341A (es) 2009-12-07
SV2004001415A (es) 2004-05-07
PA8559801A1 (es) 2003-06-30
PE20030580A1 (es) 2003-09-05
HK1069974A1 (en) 2005-06-10
ATE387190T1 (de) 2008-03-15
AR037407A1 (es) 2004-11-10
EA200400664A1 (ru) 2004-10-28
EP1458364A1 (en) 2004-09-22
TNSN04095A1 (en) 2006-06-01
SI1458364T1 (sl) 2008-08-31
CY1107966T1 (el) 2013-09-04
JP2005518360A (ja) 2005-06-23
BR0214403A (pt) 2004-10-19
KR20040079898A (ko) 2004-09-16
CA2466677A1 (en) 2003-06-05
HUP0402154A2 (hu) 2005-02-28
RS50937B (sr) 2010-08-31
WO2003045355A1 (en) 2003-06-05
DE60225331T2 (de) 2009-02-26
MA27087A1 (fr) 2004-12-20
AU2002358061A1 (en) 2003-06-10
ES2302862T3 (es) 2008-08-01
HUP0402154A3 (en) 2008-04-28
PL206016B1 (pl) 2010-06-30
EA006766B1 (ru) 2006-04-28
CN1596103B (zh) 2010-06-16
EG24124A (en) 2008-07-07
IL162143A0 (en) 2005-11-20
JP4474162B2 (ja) 2010-06-02
MXPA04004974A (es) 2004-08-11
RS47304A (en) 2006-10-27
NZ533779A (en) 2007-02-23
EP1458364B1 (en) 2008-02-27
CO5590906A2 (es) 2005-12-30
UY27549A1 (es) 2003-06-30
PL369851A1 (en) 2005-05-02
UA81615C2 (ru) 2008-01-25
ZA200404880B (en) 2005-07-29

Similar Documents

Publication Publication Date Title
NO20042713L (no) Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus
DE60038455D1 (de) Arzneimittel, umfassend eine kombination aus metformin und glibenclamide
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
ATE303802T1 (de) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DK1333887T3 (da) Kombinationsbehandling omfattende antidiabetiske og antikonvulsive midler
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
NL300288I2 (nl) Behandeling van diabetes met thiazolidinedion en metformine.
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20033556D0 (no) Farmasöytiske preparater
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
NO20022334D0 (no) Ny sammensetning og anvendelse
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
IL158593A0 (en) Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
ATE390140T1 (de) Arzneimittel, umfassend eine kombination aus metformin und glibenclamide
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
DE60029219D1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application